Abstract:ABSTRACT The induction of systemic antibody titers against hemagglutinin has long been the main focus of influenza vaccination strategies, but mucosal immunity has also been shown to play a key role in the protection against respiratory viruses. By vaccinating and challenging healthy volunteers, we demonstrated that inactivated influenza vaccine (IIV) modestly reduced the rate of influenza while predominantly boosting serum antibody titers against hemagglutinin (HA) and HA stalk, a consequence of the low neuraminidase (NA) content of IIV and the intramuscular route of administration. The viral challenge induced nasal and serum responses against both HA and NA. Correlations between mucosal IgA and serum IgG against specific antigens were low, whether before or after challenge, suggesting a compartmentalization of immune responses. Even so, volunteers who developed viral shedding for multiple days had lower baseline titers across both systemic and mucosal compartments as compared to those with no shedding or a single day of shedding. Regression analysis showed that pre-challenge HA inhibition titers were the most consistent correlate of protection across clinical outcomes combining shedding and symptoms, with NA inhibition titers and HA IgG levels only predicting the duration of shedding. Despite the inclusion of data from multiple binding and functional antibody assays against HA and NA performed on both serum and nasal samples, multivariate models were unable to account for the variability in outcomes, emphasizing our imperfect understanding of immune correlates in influenza and the importance of refining models with assessments of innate and cellular immune responses. IMPORTANCE The devastating potential of influenza has been well known for over 100 years. Despite the development of vaccines since the middle of the 20th century, influenza continues to be responsible for substantial global morbidity and mortality. To develop next-generation vaccines with enhanced effectiveness, we must synthesize our understanding of the complex immune mechanisms culminating in protection. Our study outlines the differences in immune responses to influenza vaccine and influenza infection, identifying potential gaps in vaccine-induced immunity, particularly at the level of the nasal mucosa. Furthermore, this research underscores the need to refine our imperfect models while recognizing potential pitfalls in past and future attempts to identify and measure correlates of protection.

Evaluation of Vaccine Immunogenicity—Correlates to Real-World Protection: Influenza

Developing Correlates of Protection for Vaccines Is Needed More than Ever—Influenza, COVID-19 and RSV Infection

Unravelling influenza correlates of protection: lessons from human A/H1N1 Challenge

Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers

Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine

Improved resolution of influenza vaccination responses with high-throughput live virus microneutralisation

Exploring indirect protection associated with influenza immunization - A systematic review of the literature

Influenza Virus Vaccine Efficacy Based On Conserved Sequence Alignment

Opportunities and challenges for T cell-based influenza vaccines

Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity

Current challenges: from the path of "original antigenic sin" towards the development of universal flu vaccines

The human antibody response to influenza A virus infection and vaccination

Improving precision of vaccine efficacy evaluation using immune correlate data in time-to-event models

COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy

HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy

Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity

Influenza vaccine: progress in a vaccine that elicits a broad immune response

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

Seasonal influenza vaccines: Variability of immune responses to B lineage viruses

Quantifying influenza vaccine efficacy and antigenic distance

The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations